论文部分内容阅读
作者报道用双盲对照方法研究口服甲氰咪胺治疗消化性返流性食管炎患者的效果。26名中度或重度返流性食管炎患者治疗前均经详细的病史、滴酸试验、食管下段括约肌压力测量、放射线检查、内窥镜与活检而确诊,随机分为甲氰咪胺治疗组与安慰剂对照组。治疗组口服甲氰咪胺每天4次,每次400mg,饭后及睡前服;对照组则口服与甲氰咪胺外观相同的安慰剂,均服8周。任何一组患者如用药期间症状未能控制,可给予已知量的抗酸剂,并记录所用次数,其
The authors report a double-blind, controlled trial of cimetidine in patients with digestive reflux esophagitis. Twenty-six patients with moderate or severe reflux esophagitis were diagnosed with detailed medical history, drip acid test, esophageal sphincter pressure measurement, radiation examination, endoscopy and biopsy, With placebo control group. The patients in treatment group were given Cimetidine orally 4 times a day for 400mg every day after meals and at bedtime. The control group was orally given placebo with the same appearance of Cimetidine for 8 weeks. Any group of patients such as medication symptoms can not be controlled, can be given a known amount of antacid, and record the number of times, its